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Direct and Rapid Electrochemical Detection of Pseudomonas 
aeruginosa Quorum Sensing Signaling Molecules in Bacterial 
Cultures and Cystic Fibrosis Sputum Samples through Cationic 
Surfactant-Assisted Membrane Disruption 
 Alyah Buzid,[a, b] F. Jerry Reen,[c] Victor K. Langsi,[a, b] Eoin Ó Muimhneacháin,[b] Fergal O’Gara,[c, d]  
Gerard P. McGlacken,[b]  John H. T. Luong, [a, b] and Jeremy D. Glennon *[a, b] 
 
Abstract: Rapid detection of pathogenic bacteria present in 
patient samples is of utmost importance for the clinical 
management of bacterial-induced diseases. Herein, we describe 
an efficient and direct electrochemical approach for the detection 
of 2-heptyl-3-hydroxy-4-quinolone (PQS), 2-heptyl-4-
hydroxyquinoline (HHQ), and pyocyanin (PYO) as three molecular 
signatures of Pseudomonas aeruginosa (PA), a frequently 
infecting pathogen with high antibiotic resistance. The cationic 
surfactant hexadecyltrimethylammonium bromide (CTAB) 
enhances the effectiveness of an unmodified thin-film boron-doped 
diamond (BDD) electrode for the direct detection of PYO, HHQ, 
and PQS in bacterial cultures of PAO1 and PA14. Differential pulse 
voltammetry (DPV) is then used for monitoring the production of 
these microbial metabolites in bacterial cultures of PAO1 over 10 
h without any sample pretreatment. A proposed mechanism for the 
interaction of CTAB with bacteria cells is examined by zeta (ζ) 
potential measurements. Furthermore, the detection method is 
successfully extended to a clinical fluid matrix and applied to PA 
spiked cystic fibrosis (CF) sputum samples. 
Introduction 
As a gram-negative pathogenic bacterium associated with 
hospital-acquired infections, particularly in patients with 
compromised immunity, Pseudomonas aeruginosa (PA) is one 
of the prime causes of morbidity and mortality in ~80 % of 
patients with cystic fibrosis (CF).[1] This bacterium is also a 
common cause of pneumonia infections which is prevalent in 
intensive care units.[2] The infection is life-threatening, and the 
effectiveness of clinical management is limited by the ability of 
PA to form multicellular aggregates called biofilms, which act 
as a direct barrier to phagocytic cells and offers inherent 
antibiotic resistance.[3] PA produces a wide array of 
extracellular factors, which are critical for colonization and 
disease progression. Many of these factors are regulated in a 
cell density-dependent manner termed quorum sensing (QS). 
QS, an important cell-cell communication process, involves the 
production and sensing of small extracellular signaling 
molecules, enabling bacteria to monitor the population and 
respond to cell density and collectively control gene 
expression.[4] The QS framework of PA has two N-acyl 
homoserine lactone (AHL) regulatory circuits (LasIR and 
RhIIR) linked to the 2-alkyl-4(1H)-quinolone (AHQ) system to 
form a complex hierarchical network controlling gene 
expression.[5] The primary components of the AHQ signaling 
pathway are 2-heptyl-3-hydroxy-4(1H)-quinolone (referred as 
the Pseudomonas Quinolone Signal, or PQS) and its 
biosynthetic precursor, 2-heptyl-4-hydroxyquinoline (HHQ).[6] 
One class of QS-controlled extracellular factor that PA utilizes 
to establish host infections are the phenazine compounds. 
Four main phenazines are produced by PA, and these are 
pyocyanin (1-hydroxy-N-methylphenazine, PYO), 1-
phenazine-1-carboxamide (PCN), phenazine-1-carboxylic 
acid (PCA), and 5-methylphenazine-1-carboxylic acid (5-
MCA).[7] PA is the only species recognized to produce PYO, 
unlike other phenazines which are produced by species such 
as Pseudomonas fluorescens and Pseudomonas 
chlororaphis.[8] PYO is considered as an important virulence 
and pro-inflammatory factor.[9] Also, it acts as a redox-active 
molecule and generates reactive oxygen species (Figure 1). 
PYO inactivates host proteases and is considered as a direct 
determinant of PA virulence. In keeping with the QS-regulation 
of virulence systems, induction of PYO is governed by PQS in 
PA.[10] The pKa values of PQS, HHQ, and PYO are present in 
Table 1. 
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Figure 1. The chemical structures of PQS, HHQ, and PYO molecular signals. 
Table 1. Estimated pKa values of PQS, HHQ, and PYO.[11] 
 
Analyte pKa1 (NH) pKa2 (OH) pKa3 (OH)  
PQS 3.43 9.89 13.86 
HHQ 
PYO 
3.02 
4.9 
11.46 
- 
- 
- 
 
 
    Most gram-negative bacteria produce bilayered membrane 
vesicles (MVs), consisting of an outer leaflet of 
lipopolysaccharides (LPS) and an inner leaflet of 
phospholipids (PL).[12] Such MVs serve as trafficking vehicles 
for a broad range of biologically relevant molecules, including 
PQS,[13] bacterial toxins, DNA, antibiotic resistance 
determinants, and antimicrobial compounds.[14] The bacterial 
LPS has three layers: lipid A, core oligosaccharide, and 
polysaccharide O-antigen. Lipid A molecules with phosphate 
and carbonyl groups in the outer membrane (OM) display 
negative charges. The bacterial OM is stabilized in vivo by a 
cation salt bridge[12a] and provides an extra barrier which plays 
a crucial role in protecting the organism from antibiotics. PQS 
interacts strongly with LPS and is trafficked between cells via 
MVs; it is also required for MV formation.[13b] Therefore, 
extraction may be necessary for the optimal analysis of PQS 
from bacterial cultures.[1a] There is an emergence of 
antimicrobial agents to address bacterial infection through the 
interaction of cationic agents and the anionic bacterial cell 
membrane, aiming to disrupt membrane integrity and 
eradicate bacteria.[15] Among the antimicrobial agents used for 
gram-negative bacteria are, antimicrobial peptides,[16] 
antimicrobial polymers,[16b, 17] cationic steroid antibiotics,[18] and 
quaternary ammonium compounds.[19] Among them, small-
molecular-weight quaternary ammonium compounds provide 
high bactericidal potency against bacteria, both gram-positive 
and gram-negative and are widely utilized for disinfection and 
sanitation in various fields such as in hospitals and in the food 
industry.[20] Surfactants are an example of quaternary 
ammonium compounds. Synthesized [21] and hexameric, 
tetrameric, and trimeric surfactants [22] have been used 
recently to disrupt the outer membrane integrity of Escherichia 
coli and Staphylococcus aureus. The proposed mechanism of 
surfactants interaction with PA- OM is primarily based on the 
disruption of the integrity of PA- OM by electrostatic interaction 
between cationic ammonium groups of the surfactants and 
anionic groups of the LPS of PA, which undermines the barrier 
function of the outer layer.[22] Moreover, these surfactants also 
contain long hydrophobic alkyl chains which enable further 
interaction with the hydrophobic lipid membrane[22] or 
phospholipids[21], resulting in the disruption of the cellular 
membrane. 
   PA can be determined by clinical methods using either 
culture growth method or PCR. Both approaches are a time-
intensive and very costly procedure.[23] A reliable analytical 
approach is needed for the determination of AHQ signaling 
molecule levels in bacterial cultures for biological evaluation 
and the discovery of QS inhibitors. Thus far, several analytical 
techniques have been reported for quantification of PQS and 
HHQ such as unselective TLC,[24] GC-MS,[25] capillary 
electrophoresis (CE),[11b] and  LC-MS/MS methods.[1a, 26] Also, 
LC-DAD (or MS) has been applied for PYO detection in 
bacterial cultures and also in the sputum samples of CF 
patients[27], with PYO levels in CF sputum samples as high as 
27.3 µg mL-1.[27c]  However, these approaches require sample 
pre-treatment, are high cost, and entail lengthy analysis times. 
Therefore, rapid and simple electrochemical strategies would 
offer advantages over other techniques. Williams et al. [28] 
reported biosensor-based assays for PQS and HHQ whereas 
our laboratory has advocated the use of a boron-doped 
diamond (BDD) electrode for the detection of  HHQ, PQS, 
PYO,[29] 2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde 
(IQS),[30] and barakacin[31] as important signaling molecules 
and biomarkers of PA. Other electrochemical techniques have 
been successful for PYO detection.[7, 32] Webster et al. [32g] 
successfully reported the detection of PYO in human fluids 
including urine, sputum, bronchoalveolar lavage fluid (BALF), 
and whole blood. 
    Considering several attractive features of the BDD thin-film 
electrode[33], this report reveals the use of the BDD electrode, 
without modification, for the direct determination of PYO, HHQ, 
and PQS in bacterial cultures of PA (wild-type) without the prior 
requirement to extract the microbial metabolites from the 
culture. This fast and simple method requires the addition of 
the cationic surfactant hexadecyltrimethylammonium bromide 
(CTAB) to the cell culture medium, and the effects of CTAB 
concentration, pH, and incubation time investigated. The 
mechanism of CTAB interaction with the bacteria cells was 
examined by zeta (ζ) potential measurement. The established 
conditions for the analysis were then applied to monitor the 
production of signaling molecules in the bacterial PAO1 strain 
and to detect the signals in CF patient sputum spiked with the 
bacterial strain PA- PAO1 using the bare BDD electrode. 
    The level of HHQ and PQS released in pediatric CF patients 
is higher when compared to laboratory strains.[34] Single 
analyte detection has a significant limitation in clinical 
pathogen detection due to the genetic heterogeneity that exists 
among PA.[35] Therefore, the detection of PYO alone as 
described in Alatraktchi et al.[36] using disposable screen-
printed gold electrodes and Webster et al.[29h] may not be 
sufficient to ascertain the absence or presence of PA.  
As a continuing effort of our research activities, this work 
unravels the direct detection of all three signaling molecules in 
CF sputum samples based on in situ cationic surfactant-
assisted membrane disruption. CTAB, which removes the 
lipids of the cell membranes, thus obviating the time-
consuming solvent and solid phase extraction step, is 
advocated for this purpose considering its low cost and 
availability. The BDD electrode is not subjected to any fouling 
during the analysis, a classical problem associated with 
screen-printed electrodes (SPE) [32g, 36] or other carbon based 
materials.   
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Results and Discussion 
Differential Pulse Voltammetry (DPV) of Surfactant-
Treated Bacterial Cultures 
 
The DPV for PYO, PQS, and HHQ individually and for a 
standard mixture of PYO, PQS, and HHQ in the presence of 
CTAB are shown in Figure 2. There were two detection 
windows for both PYO and PQS whereas HHQ exhibited one 
single peak. For PYO, the first pronounced peak at the 
negative potential reflects the oxidation of PYO whereas the 
second peak at a high potential is responsible for the 
polymerization of this compound (Figure 2a). The negative 
peak of PYO has been overlapped by some endogenous 
compounds in biological fluids including human saliva.[36] PQS 
also has two oxidation peaks, reflecting the presence of –NH 
in the phenol ring.[29a] The DPV for PYO, PQS, and HHQ in the 
absence of CTAB can be viewed in Figure S1. The main 
purpose of using CTAB here is to disrupt the cell, effecting the 
release of the signaling molecules. CTAB is hydrophobic and 
not electroactive, so it should not appreciably affect the 
electrochemical behavior of the BDD electrode (Figure S2). 
However, CTAB would not be expected to enhance the 
electrical performance, but rather increase the levels of the 
signal molecules presented to the electrode. The extraction of 
intracellular molecules from bacterial cells is tedious and prone 
to noticeable errors and also more challenging when only 
minute sample volumes (e.g., patient sputum) are available. 
 
Figure 2. DPV of a) 10 µM PYO; b) 50 µM PQS; c) 50 µM HHQ; and (d) a 
standard mixture of 10 µM PYO, 50 µM PQS, and 50 µM HHQ with 1.0 mM 
CTAB. 50 mM acetate buffer, pH 5.0 consisting of 20 % ACN was used as 
an electrolyte for the detection on the BDD electrode vs. Ag/AgCl. 
    As discussed in the introduction section, the proposed 
mechanism of CTAB interaction with the PA- OM is primarily 
based on electrostatic and hydrophobic interactions,[21-22] 
resulting in disruption of the cellular membrane (Scheme 1). 
This is similar to the effect described for surfactants on E. coli 
and S. aureus.[21-22] Furthermore, this surfactant aids in the 
solubilization of PQS from its hydrophobic affinity for the lipid-
rich membrane of the bacterial cells (Scheme S1).[37] 
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Scheme 1. Schematic diagram of membrane vesicles disruption by cationic 
surfactant (CTAB) on the PA. 
    Therefore, the effect of the cationic surfactant (CTAB) on the 
DPV of the bacterial culture PAO1 was evaluated (Figure 3). 
All measurements were performed in the presence of the 
bacteria. Varying CTAB concentrations (0, 0.5, 1.0, and 2.0 
mM) were investigated while maintaining the pH and 
equilibration time at pH 7.0 and 5 min, respectively. Figure 3a 
clearly shows that PQS and HHQ were not detected in the 
absence of CTAB. The concentration of 1.0 mM and 2.0 mM 
CTAB provided sufficient cell membrane disruption to release 
and allow detection of PQS and HHQ from the lipid membrane. 
Both concentrations result in the disappearance of the 
oxidation peak of PYO at ~ + 0.8 V. However, 1.0 mM provides 
better detectability and higher peak current of PQS and HHQ 
than 2.0 mM. It is worth noting that, while the addition of CTAB 
at these concentrations led to an increased lag phase in PA- 
PAO1 growth, exponential phase, and comparable biomass 
were achieved (Figure S3a). However, in the longer term, 
following 4-day incubation, cell viability was significantly 
reduced in the presence of 2.0 mM CTAB (Figure S3b). Indeed 
concentration-dependent suppression of microbial growth by 
CTAB has previously been outlined in previous reports, both of 
fungal cells [38] and bacterial organisms.[38-39] Therefore, 1.0 
mM was selected as the effective CTAB concentration. 
Different CTAB pH solutions (pH 6.0 - 8.0) were studied with 
the concentration and equilibration time constant at 1.0 mM 
and 5 min, respectively. At pH 7.0, an apparent peak 
separation of PYO and PQS was achieved in the potential 
range of + 0.85 V to + 1.15 V (Figure 3b). The varying of the 
equilibration time (0 - 30 min) of surfactants with bacterial 
culture was also studied. The higher peak intensities of the 
target analytes were obtained using 5 min as the equilibration 
time (Figure 3c). This is consistent with previous reports which 
described the adsorption of CTAB on the PA surface reaching 
equilibrium in less than 5 min.[19b] No attempts were made to 
grow PA bacterial cultures in the absence of oxygen because 
anaerobic PA limits PQS production and subsequently limits 
all PQS controlled virulence factors.[40] Furthermore, it is time-
consuming to remove oxygen from the sample with nitrogen 
bubbling (> 30 min), and this step is more problematical with 
minute sample volumes. The addition of an electron receptor 
also adds another step and such a compound might also be 
electroactive and interferes with the measurement of the 
biomarkers, a subject of future endeavors. 
    In order to show that the applicability of the method was not 
restricted only to PAO1, the developed approach was also 
applied to the PA- PA14 strain. Under the chosen conditions, 
the DPV of bacterial cultures PAO1 and PA14 with and without 
CTAB treatment can be compared (Figure 4). The DPV shows 
that bacterial PA- PA14 strain produced ~ 3 times more PYO 
and HHQ and ~ 2 times more PQS than the PA- PAO1 strain. 
    As also shown in Figure 4, PYO is oxidized at a negative 
potential (- 0.14 V) whereas the second peak at + 0.8 V is 
responsible for the polymerization of this oxidized compound. 
CTAB displays ionic and hydrophobic interactions with the 
oxidized PYO to form a stable complex. This complex 
becomes more resistant to oxidation/polymerization, resulting 
in a noticeable decrease or even disappearance of the PYO 
peak at + 0.8 V. 
 
Figure 3. DPV responses towards the effect of varying a) CTAB 
concentrations (0 - 2.0 mM) at pH 7.0 and equilibration at 5 min ; b) CTAB 
pH (6.0 - 8.0) at 1.0 mM CTAB and equilibration at 5 min; and c) equilibration 
time (0 - 30 min) at 1.0 mM CTAB and pH 7.0. Bacterial PAO1 strain was 
grown for 9 h with the OD600 nm of 2.21. 50 mM acetate buffer, pH 5.0 
consisting of 20 % ACN was used as an electrolyte for the detection on the 
BDD electrode vs. Ag/AgCl. 
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Figure 4. a) DPV response towards the PAO1 strains without and with 
CTAB which was grown for 9 h and the OD600 nm = 2.21, and b) DPV 
response towards the PA14 strains without and with CTAB which was grown 
for 7 h and the OD600 nm = 2.5. 50 mM acetate buffer, pH 5.0 consisting of 
20 % ACN was used as an electrolyte for the detection on the BDD electrode 
vs. Ag/AgCl. 
    The zeta potential (ζ) provides further evidence for the 
selective binding of CTAB to PA cell membrane. Upon the 
addition of CTAB, the ζ potential for PA becomes less negative 
(Table 2), indicating that the active CTAB binding to the outer 
membrane of PA.[17] 
 
Table 2. Zeta potential (ζ) of bacterial culture PAO1 before and after the 
addition of CTAB. 
Sample Zeta potential (ζ, mV)[a] 
PAO1 wild-type -29.8 ± 1.5 
PAO1 wild-type +   CTAB -25.7 ± 1.4 
[a] Zeta potential of the PAO1 strains in the absence and presence of CTAB. 
Measurements were performed in triplicate at 30 ºC, and the data were 
presented as the mean ± standard deviation (SD). The bacterial PAO1strain 
was grown for 9 h with the OD600 nm of 2.87. 
 
    The analytical parameters for the simultaneous 
determination of PYO, HHQ, and PQS containing 1.0 mM 
CTAB, pH 7.0 and an equilibration time of 5 min in LB media 
are presented in Table 3. The calibration curve of target 
analytes exhibited an excellent linearity (R2 ≥ 0.995) in the 
linear range of 5 - 50 µM. The limit of detection (LOD) was 
estimated from the regression line of the calibration curve in 
the LB media (n = 3). The LOD for PYO, HHQ, and PQS in the 
LB media was 2.06, 3.61, and 4.85 µM, respectively, whereas 
the LOD of PYO, HHQ, and PQS in the buffer solution was 
1.74, 2.48, and 1.07 µM, respectively. The reproducibility of the 
BDD electrode for signaling molecules detection was studied. 
The BDD electrode was used for repeated detection (3 times) 
for 30 µM of PYO, HHQ, and PQS each. The relative standard 
deviation (R.S.D %) values of the potential were 1.76 %, 
2.54 %, and 3.64 % for PYO, HHQ, and PQS, respectively, 
representing acceptable precision of the BDD electrode. The 
DPV traces associated with a standard curve can be seen in 
Figure S4. The resulting LOD values deserve a brief comment 
here since such values are highly dependent upon the 
electrolyte medium. Without CTAB, the BDD electrode vs. 
Ag/AgCl in 50 mM acetate buffer, pH 5.0 containing 20% ACN 
exhibits very low LOD values for PYO, HHQ, and PQS: 50 nM, 
250 nM, and 250 nM, respectively as reported by Buzid et 
al.[29b] However, such corresponding values are only 0.15 μM, 
0.62 μM, and 1.25 μM, when the analysis is performed in the 
CF sputum sample.[29b] The LOD values obtained for the above 
biomarkers are 2.06, 3.61, and 4.85  μM when the DPV 
measurement is performed in the LB medium with 1.0 mM 
CTAB (Table 3), all well within the physiologically relevant 
range reported for CF sputum.[27c, 41] The rationale behind such 
differences in LOD was not understood, but the LB medium 
contains casein enzymic hydrolysate (10 g/L) and yeast extract 
(5 g/L), which might adsorb on the BDD electrode during the 
DPV measurement, resulting in higher LOD values for the 
biomarkers. The presence of CTAB in the electrolyte does not 
exhibit an appreciable effect on the electroanalysis of BDD as 
mentioned earlier.   
 
Direct Monitoring of HHQ, PQS, and PYO Production in the 
Bacterial Strain PAO1 and Analysis of Clinical Samples  
 
The rapid and early detection of PA and other pathogenic or 
contaminant organisms would be a significant advance for 
both clinical and industrial applications. Furthermore, direct 
detection without any pre-treatment step would also be 
advantageous in terms of total analysis time and reproducibility. 
Therefore, direct time-course analysis and matrix interference 
assays were performed to ascertain the applicability of the 
developed method. A time-course analysis of bacterial PAO1 
strain carrying a pqsA-lacZ promoter fusion was performed for 
10 h to monitor the real-time concentration profiles of HHQ, 
PQS and PYO from an early log phase into the stationary 
phase of growth. In addition to measuring the DPV response 
on the BDD electrode, the kinetics of pqsA promoter activity 
was measured in tandem, providing a comparator profile for 
signal production at the level of gene expression. Both HHQ 
and PQS are co-inducers of the PqsR transcriptional regulator 
that controls the expression of the pqsA-E biosynthetic 
operon.[42] As such, increased detection of these molecules 
should be preceded by a similar increase in pqsA-E gene 
expression via the pqsA promoter. Samples were taken from 
cultures at 1 h intervals from the mid-log phase and monitored 
as before (Figure 5). No measurement was taken between 0 
to 4 h because the significant production of the three signaling 
molecules only emerged after 4 h into the experiment (between 
late log phase and entry into the stationary phase of growth), 
consistent with the established kinetics of AHQ signal 
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production in PA.[1a, 27a] HHQ and PQS were initially identified 
at the highest concentration. As the cells entered the stationary  
phase, both PQS, and PYO become more abundant.[27a, 43] 
Data was consistent with the parallel monitoring of pqsA 
promoter activity in these cells, with increased HHQ and PQS 
production occurring in tandem with a spike in pqsA promoter 
activity, signaling activation of the system in the cell culture 
(Figure S5). 
 
Figure 5. a) DPV response towards bacterial PA- PAO1 strain in LB media 
as a function of time; and b) growth curve for the production of HHQ, PQS, 
and PYO in bacterial PAO1 strain in LB media was carried out for 10 h. Cell 
density was measured regarding OD600 nm. All measurements were made in 
triplicate in the presence of CTAB. The oxidation peaks of - 0.14 V and + 0.5 
V were presented for PYO and PQS, respectively. 50 mM acetate buffer, pH 
5.0 consisting of 20 % ACN was used as an electrolyte for the detection on 
the BDD electrode vs. Ag/AgCl. 
    Matrix interference is a vitally important consideration, and it 
is essential that detection of the analytes is achievable in 
clinical samples to which the system may be applied. CF 
sputum samples contain a significant amount of phospholipids, 
proteins, and DNA, which increase the viscosity of the sputum 
samples, in addition to serum transudates and exudates as 
well as dead leukocytes, bacteria, bacteria metabolites, and 
cellular debris.[44] However, blank sputum samples from the 
lungs of pediatric patients were tested, and no oxidation peaks 
were obtained from the DPV of blank CF sputum samples 
consistent with the absence of PA. Sputum samples were then 
spiked with aliquots of 8 h cultures of PAO1, equilibrated for 
20 min, and analyzed for the presence of all three analytes (n 
= 3). In our previous work,[29b] the production of the signaling 
molecules PYO, HHQ, and PQS in growing the cultures and 
the sputum samples was performed following 11 days 
incubation. In order to measure the effect of CTAB on 
standardized samples, spiking the sputum samples with 
equilibrated amounts of PA provided a fast, standardized and 
straightforward approach. Notably, neither PQS nor HHQ were 
detected in the absence of CTAB in both the cultures and 
spiked sputum samples (Figure 6a). Upon the addition of 
CTAB, all three signals were identified in both the culture and 
the spiked sputum sample, emphasizing the effectiveness of 
CTAB in enhancing presentation of the signal molecules to the 
electrode, and indicating that this clinically relevant matrix 
does not interfere with the application of this direct detection 
procedure (Figure 6b). 
 
Table 3. Calibration curve of PYO, HHQ, and PQS in LB media using DPV on the BDD electrode.  
Analyte Linear range (µM) Linear regression equation (I: µA, C: µM) Correlation coefficient (R2) LOD (µM)[a R.S.D % (n = 3)[b] 
PYO 5 - 50 I PYO = 3.28 x 10-9 C + 2.17 x 10-9 0.995 2.06 1.76 
HHQ 5 - 50 I HHQ = 1.76 x 10-10 C + 2.32 x 10-9 0.997 3.61 2.54 
PQS 5 - 50 I PQS = 1.58 x 10-10 C – 4.22 x 10-9 0.982 4.85 3.64 
[a] LOD calculated as 3 x standard deviation intercept /slope. [b] R.S.D (%) calculated from triplicates DPV measurements in the LB media 
for the potential at 30 µM each of PYO, HHQ, and PQS (n = 3). 
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Figure 6. DPV of a blank CF sputum sample, bacterial PAO1 strain, and a 
CF sputum sample mixed with bacterial culture PAO1. a) the bacterial strain 
PAO1 and CF sputum samples were diluted in 50 mM phosphate buffer, pH 
7.0 at a ratio of 1:4, respectively. b) the bacterial strain PAO1 and CF sputum 
samples were treated with 1.0 mM CTAB prepared in 50 mM phosphate 
buffer (pH 7.0) at a ratio of 1:4, respectively. Electrolyte: 50 mM acetate 
buffer, pH 5.0 consisting of 20 % ACN was used for the detection on the 
BDD electrode vs. Ag/AgCl.  
Conclusion 
In brief, the unmodified BDD electrode was successfully 
utilized for a fast and direct voltammetric analysis of PYO, 
HHQ, and PQS in the bacterial cultures of strains PAO1 and 
PA14 using CTAB, without the requirement for liquid-liquid or 
solid-phase extraction. The method was applied to 
simultaneous monitoring of PYO, HHQ, and PQS production 
in PAO1 over 10 h. The time-course of the quorum sensing 
metabolites followed the established kinetics, with HHQ and 
PQS shown to be produced maximally prior to entry into the 
stationary phase of the bacterial growth curve. Additionally, the 
method revealed the expected kinetics of PYO toxin 
production, occurring after the initial induction of HHQ and 
PQS. Finally, the application of the developed method was 
successfully extended to CF sputum, showing applicability for 
direct detection of these PA signature signaling molecules in 
this clinical matrix. 
 
 
Experimental Section 
Chemicals and Materials 
Sodium phosphate monobasic, acetic acid, sodium phosphate dibasic, 
sodium acetate anhydrous, ethanol, acetonitrile (ACN), CTAB, 
pyocyanin, β-mercaptoethanol, and o-nitrophenyl β-D-
galactopyranoside were all purchased from Sigma-Aldrich (Dublin, 
Ireland). Phosphate buffer solutions (50 mM, pH 6.0 - 8.0) were used 
to study the effect of pH on CTAB. An electrolyte of acetate buffer (50 
mM, pH 5.0, with 20 % ACN) was utilized for the detection. ACN was 
used to prepare the stock solution of 2.0 mM PQS, HHQ, and PYO. All 
reagents were of the analytical grade, and all aqueous solutions were 
prepared with deionized water obtained from a water purification 
system (Millipore, Bedford, MA).  
 Apparatus 
Electroanalysis was performed using a CHI1040A electrochemical 
workstation (CH Instrument, Austin, TX) with cyclic voltammetry (CV) 
and DPV. The electrochemical cell consists of three electrodes using 
the BDD (0.5 mm, thickness) as a working electrode with a diameter of 
3 mm, 0.1 % doped boron (Windsor Scientific, Slough Berkshire, UK). 
An Ag/AgCl (3M KCl) (BASi Analytical Instruments, West Layette, IN) 
serves as a reference electrode whereas a Pt wire is used as a counter 
electrode (Sigma-Aldrich, Dublin, Ireland). 
Synthesis of HHQ and PQS 
HHQ and PQS were synthesized as previously described by 
McGlacken et al.[6b] HHQ and PQS were deemed analytically pure 
based on NMR analysis. All spectra were consistent with that 
previously published.[11b] These synthesized compounds, in addition to 
standard PYO, have been used for control experiments (Figure 2, and 
Figure S1), calibration curve measurements (Table 3, and Figure S4). 
 Electrode Preparation 
The BDD electrode was polished with wet papers (Nylon and 
MasterTex), followed by alumina slurries (0.3 µm and 0.05 µm, 
respectively) (Buehler, UK) until a mirror finish was obtained. After 
washing with deionized water, the electrode was sonicated in ethanol 
and deionized water for 5 and 10 min, respectively. Subsequently, the 
electrode was voltammetric cleaned by CV between - 1.0 and + 2.0 V 
vs. Ag/AgCl (3M KCl) at a scan rate of 100 mV s-1 in a 50 mM acetate 
buffer (pH 5.0) until a steady CV profile was obtained.  
Direct Analysis and Monitoring the Production of PQS, HHQ, and 
PYO in Bacterial Strain PA- PAO1 Cultures and Spiked Sputum 
In brief, overnight bacterial cultures of PAO1 and PA14 were 
transferred into a fresh Luria-Bertani (LB) broth (OD600 nm 0.05) using a 
modified version of the Fletcher protocol.[28b] The bacterial culture 
PAO1 was grown for 9 h, and aliquots diluted and equilibrated for 5 min 
with 1.0 mM CTAB prepared in 50 mM phosphate buffer, pH 7.0 (1:4, 
v/v, sample: surfactant). For a direct analysis in PA14, the bacterial 
culture was grown for 7 h and treated with 1.0 mM CTAB under the 
same conditions. For a time-course study, 0.5 mL bacterial PAO1 
culture aliquots were taken at regular time intervals. The growth and 
promoter activity was measured by the OD600 nm and Miller Assay, 
respectively. All bacterial culture samples were treated with 1.0 mM 
CTAB prepared in 50 mM phosphate buffer, pH 7.0 (1:4, v/v, sample: 
CTAB) and equilibrated for 5 min. Then, the sample (0.2 mL) was 
diluted in the electrolyte 50 mM acetate buffer, pH 5.0 containing 20 % 
ACN (0.8 mL). Patient sputum samples were spiked with bacterial 
culture PAO1 (1:4, v/v, sputum sample: bacterial culture was grown for 
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8 h), equilibrated for 20 min and then treated with CTAB as mentioned 
earlier. 
Promoter Fusion Assays  
Promoter fusions assays were performed using the pqsA-lacZ reporter 
plasmid pLP0996, which is routinely used to investigate promoter 
activity of the autoinducing pqsA-E PQS biosynthetic operon.[45] Briefly, 
overnight cultures of PAO1 and isogenic pqsA- mutant strains 
containing the pqsA-lacZ promoter fusion were diluted to Abs600 nm 0.05 
in 20 mL LB and grown at 37 °C with shaking at 180 rpm. The β-
galactosidase activity was measured over time as described by 
Miller.[46]  
Zeta Potential Measurements 
The PAO1 wild-type was grown for 9 h, diluted with 1.0 mM CTAB (1:4, 
v/v, sample: CTAB), and equilibrated for 5 min. Then, the samples 
containing CTAB were diluted with deionized water (1:2, v/v) and kept 
on ice for zeta potential measurements. As a control (without CTAB), 
the PAO1 wild-type was grown for 9 h, diluted with 50 mM phosphate 
buffer, pH 7.0 (1:4, v/v, sample: phosphate buffer, pH 7.0) and 
equilibrated under the same conditions. 
Growth and Viability Assays  
PAO1 pLP0996, PAO1 pqsA- pLP0996, and PA14 were grown 
overnight at 37oC with shaking in LB media. Cells were subsequently 
transferred into fresh LB media, starting OD600 nm 0.05, and treated with 
increasing concentrations of CTAB (0 mM, 0.125 mM, 0.25 mM, 0.5 
mM, 1 mM, and 2 mM). After transfer to multi-well plates, growth was 
monitored static at 37 oC (with shaking for 10 sec at 30 min intervals 
prior to measurement) over 25 h. In addition, CTAB treated cells were 
transferred into 1.5 mL tubes and incubated at 37 oC for 4 days at which 
point serial dilutions on LB plates were performed to quantify the viable 
cell count. All experiments were performed using three independent 
biological replicates. 
Data Analysis 
All data were processed using Origin Pro 8.5.1 (OriginLab, USA). Each 
measurement was repeated in triplicate with the results presented as 
the mean ± SD. For the monitoring study of the bacterial PA- PAO1 
strain, such complex DPV data were processed using the second 
derivative of the peak area.  
Compliance with Ethical Standards 
Sputum samples were collected from pediatric patients attending the 
CF clinic at Cork University Hospital, Ireland. Ethical approval was 
granted by the Clinical Research Ethics Committee (CREC) for sputum 
collection, and samples were handled according to the approved 
guidelines. Written informed consent from all patients/guardians was 
obtained for acquisition and analysis outlined in this study. 
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